High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine

Leuk Lymphoma. 2018 May;59(5):1264-1267. doi: 10.1080/10428194.2017.1375108. Epub 2017 Sep 13.

Authors

Maria Dimou¹, Maria Roumelioti¹, Aglaia Dimitrakopoulou², Catherin Bitsani¹, Sotiria Kotsanti¹, Panayiota Petsa¹, Paraskevi Papaioannou¹, Marie-Christine Kyrtsonis¹, Panayiotis Panayiotidis¹

Affiliations

¹ a First Propedeutic Department of Internal Medicine, Hematology Unit , National and Kapodistrian University of Athens, Laikon General Hospital , Athens , Greece.
² b Department of Immunology and Histocompatibility , Laiko Geniko Nosokomeio , Athens , Greece.

PMID: 28901815
DOI: 10.1080/10428194.2017.1375108

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antimetabolites, Antineoplastic / adverse effects
Azacitidine / adverse effects*
CD5 Antigens / metabolism*
Humans
Lymphocytosis / chemically induced
Lymphocytosis / pathology*
Lymphoma, B-Cell / etiology*
Male
Myelodysplastic Syndromes / complications
Myelodysplastic Syndromes / drug therapy*
Myelodysplastic Syndromes / pathology
Peritoneum / drug effects
Peritoneum / pathology*
Prognosis

Substances

Antimetabolites, Antineoplastic
CD5 Antigens
Azacitidine